|
Market Cap (5-Jun) $23,079,360 (1,609th) |
Close (25-Oct) $0.048 |
Volume (25-Oct) 0 |
Shortsold (25-Jun) 3,768 (0.00%) (647th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.019 |
SUD released this announcement to the ASX on 29 March 2021, 8:25. The announcement is not marked as price sensitive, and is 3 page(s) in length and 187.3kb in size.
You can view all announcements from SUD and see how they appear on a price chart on the announcements page.
At the date of this announcement, SUD was 0.001% short sold according to ASIC data. It was ranked the 647th most shorted stock on the ASX. It remains ranked 647th as of the latest reported data (25 June 2021).
| Other Recent Announcements from SUD | |
|---|---|
| SUDA becomes Arovella Therapeutics | 22 October 2021, 8:20 |
| Chile Ministry of Health Approval Granted for ZolpiMist | 21 October 2021, 10:00 |
| Results of General Meeting | 14 October 2021, 13:51 |
| Anagrelide Project Update | 29 March 2021, 8:25 |
| Appendix 3G | 3 March 2021, 16:43 |
| Anagrelide Project Update | 26 February 2021, 8:46 |
| Appendix 4D & Interim Financial Half Year Report FY2021 | 26 February 2021, 7:59 |
You must be logged in to post a reply.
